Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

ClinicalTrials.gov ID: NCT03863080

Public ClinicalTrials.gov record NCT03863080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Extension of RVT-1401 in Myasthenia Gravis Patients

Study identification

NCT ID
NCT03863080
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Immunovant Sciences GmbH
Industry
Enrollment
17 participants

Conditions and interventions

Interventions

  • RVT-1401 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 20, 2019
Primary completion
Oct 6, 2020
Completion
Dec 20, 2020
Last update posted
Dec 19, 2023

2019 – 2020

United States locations

U.S. sites
15
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
IMC/Diagnostic and Medical Clinic Mobile Alabama 36604
Phoenix Neurological Associates Phoenix Arizona 85018
The Neurology Center of Southern California Carlsbad California 92011
UC Irvine - MDA ALS and Neuromuscular Center Orange California 92868
Care Access Research Pasadena California 91101
CSNA Colorado Springs Colorado 80907
Yale School of Medicine Department of Neurology New Haven Connecticut 06510
Neurological Services of Orlando Orlando Florida 32806
Rare Disease Research Atlanta Georgia 30318
University of Minnesota - Department of Neurology Minneapolis Minnesota 55455
Dent Institute Amherst New York 14221
University of Buffalo Buffalo New York 14260-1660
Hospital for Special Surgery New York New York 10021
Allegheny Neurological Associates Pittsburgh Pennsylvania 15212
UTSW James W. Aston Ambulatory Care Center - Neurology Clinic Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03863080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03863080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →